Tenaya Therapeutics (TNYA) Competitors $1.97 -0.05 (-2.48%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TNYA vs. ADAP, PGEN, BCAB, LIAN, QURE, NUVB, TRML, TRDA, ORIC, and EXAIShould you be buying Tenaya Therapeutics stock or one of its competitors? The main competitors of Tenaya Therapeutics include Adaptimmune Therapeutics (ADAP), Precigen (PGEN), BioAtla (BCAB), LianBio (LIAN), uniQure (QURE), Nuvation Bio (NUVB), Tourmaline Bio (TRML), Entrada Therapeutics (TRDA), ORIC Pharmaceuticals (ORIC), and Exscientia (EXAI). These companies are all part of the "medical" sector. Tenaya Therapeutics vs. Adaptimmune Therapeutics Precigen BioAtla LianBio uniQure Nuvation Bio Tourmaline Bio Entrada Therapeutics ORIC Pharmaceuticals Exscientia Adaptimmune Therapeutics (NASDAQ:ADAP) and Tenaya Therapeutics (NASDAQ:TNYA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, media sentiment, institutional ownership, community ranking and earnings. Which has stronger earnings and valuation, ADAP or TNYA? Adaptimmune Therapeutics has higher revenue and earnings than Tenaya Therapeutics. Adaptimmune Therapeutics is trading at a lower price-to-earnings ratio than Tenaya Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdaptimmune Therapeutics$60.28M2.49-$113.87M-$0.22-2.67Tenaya TherapeuticsN/AN/A-$124.08M-$1.44-1.37 Is ADAP or TNYA more profitable? Tenaya Therapeutics has a net margin of 0.00% compared to Adaptimmune Therapeutics' net margin of -25.43%. Adaptimmune Therapeutics' return on equity of -83.38% beat Tenaya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Adaptimmune Therapeutics-25.43% -83.38% -15.49% Tenaya Therapeutics N/A -86.17%-71.14% Do analysts rate ADAP or TNYA? Adaptimmune Therapeutics presently has a consensus target price of $3.16, suggesting a potential upside of 439.12%. Tenaya Therapeutics has a consensus target price of $14.75, suggesting a potential upside of 648.73%. Given Tenaya Therapeutics' higher probable upside, analysts plainly believe Tenaya Therapeutics is more favorable than Adaptimmune Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adaptimmune Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Tenaya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, ADAP or TNYA? Adaptimmune Therapeutics has a beta of 2.26, suggesting that its stock price is 126% more volatile than the S&P 500. Comparatively, Tenaya Therapeutics has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500. Do insiders & institutionals believe in ADAP or TNYA? 31.4% of Adaptimmune Therapeutics shares are held by institutional investors. Comparatively, 90.5% of Tenaya Therapeutics shares are held by institutional investors. 12.4% of Adaptimmune Therapeutics shares are held by insiders. Comparatively, 32.8% of Tenaya Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to ADAP or TNYA? In the previous week, Adaptimmune Therapeutics had 1 more articles in the media than Tenaya Therapeutics. MarketBeat recorded 23 mentions for Adaptimmune Therapeutics and 22 mentions for Tenaya Therapeutics. Tenaya Therapeutics' average media sentiment score of 0.87 beat Adaptimmune Therapeutics' score of 0.39 indicating that Tenaya Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adaptimmune Therapeutics 3 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Tenaya Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community prefer ADAP or TNYA? Adaptimmune Therapeutics received 284 more outperform votes than Tenaya Therapeutics when rated by MarketBeat users. However, 80.00% of users gave Tenaya Therapeutics an outperform vote while only 62.95% of users gave Adaptimmune Therapeutics an outperform vote. CompanyUnderperformOutperformAdaptimmune TherapeuticsOutperform Votes31662.95% Underperform Votes18637.05% Tenaya TherapeuticsOutperform Votes3280.00% Underperform Votes820.00% SummaryTenaya Therapeutics beats Adaptimmune Therapeutics on 9 of the 16 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Tenaya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNYA vs. The Competition Export to ExcelMetricTenaya TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$156.07M$2.91B$5.07B$8.66BDividend YieldN/A1.79%5.10%4.06%P/E Ratio-1.3743.08101.9217.45Price / SalesN/A217.681,198.0869.07Price / CashN/A178.0140.9736.36Price / Book1.394.096.335.87Net Income-$124.08M-$42.42M$119.64M$225.66M7 Day Performance-28.62%-10.63%-5.13%-1.34%1 Month Performance-8.37%-5.81%-2.72%1.15%1 Year Performance4.79%24.19%31.08%24.02% Tenaya Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNYATenaya Therapeutics4.0177 of 5 stars$1.97-2.5%$14.75+648.7%+8.8%$156.07MN/A-1.37110ADAPAdaptimmune Therapeutics2.1677 of 5 stars$0.80-2.6%N/A+17.3%$205.18M$60.28M-2.29449Analyst ForecastAnalyst RevisionNews CoveragePGENPrecigen3.9501 of 5 stars$0.99-1.4%N/A-28.7%$249.28M$4.39M-1.83202Analyst ForecastAnalyst RevisionNews CoverageGap UpBCABBioAtla2.6483 of 5 stars$2.32-2.1%N/A+4.0%$112.15M$250,000.00-1.3660Analyst DowngradeShort Interest ↓Analyst RevisionNews CoverageLIANLianBio1.1353 of 5 stars$0.30flatN/A-92.7%$32.42MN/A-0.37110Gap DownQUREuniQure3.4776 of 5 stars$7.35-4.0%N/A-3.5%$358.24M$15.84M-1.48500Short Interest ↓NUVBNuvation Bio2.3415 of 5 stars$3.02+0.3%N/A+101.5%$752.72M$2.16M-1.3960TRMLTourmaline Bio1.9857 of 5 stars$28.70+1.3%N/A+53.9%$735.90MN/A-10.1844Analyst RevisionNews CoverageTRDAEntrada Therapeutics2.3061 of 5 stars$19.61-1.4%N/A+16.1%$733.81M$215.23M12.33110Insider SellingORICORIC Pharmaceuticals4.1718 of 5 stars$10.25-0.5%N/A+29.8%$723.06MN/A-5.8680Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpEXAIExscientia2.7457 of 5 stars$5.97+0.2%N/A-21.4%$721.70M$21.02M-4.59280News CoverageGap Down Related Companies and Tools Related Companies Adaptimmune Therapeutics Competitors Precigen Competitors BioAtla Competitors LianBio Competitors uniQure Competitors Nuvation Bio Competitors Tourmaline Bio Competitors Entrada Therapeutics Competitors ORIC Pharmaceuticals Competitors Exscientia Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TNYA) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenaya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenaya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNYA Stock Alerts